Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction

Coronary Artery Disease

Volumn 20, Issue 6, 2009, Pages 370-375

  Selcuk, Hatice ^a,b   Temizhan, Ahmet ^a   Selcuk, Mehmet Timur ^a   Sen, Taner ^a   Maden, Orhan ^a   Tekeli, Sebahat ^a   Sasmaz, Ali ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b KC Goksupark Havuzlu Evler A1 ^*  (Turkey)

Author keywords

Cardiovascular events; Metabolic syndrome; Myocardial infarction

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROGNOSIS; WAIST HIP RATIO;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TURKEY;

EID: 69349103722     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32832ed31e     Document Type: Article

References (27)

1. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109:42-46. (Pubitemid 38056019)
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716. (Pubitemid 35403784)
3. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164:1066-1076. (Pubitemid 38668985)
4. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93:159-164. (Pubitemid 38058723)
5. Petrina M, Goodman SG, Eagle KA. The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: current status in an era of revascularization and reperfusion. Am Heart J 2006; 152:11-18. (Pubitemid 43974734)
6. Scirica BM, Cannon CP, McCabe CH, Murphy SA, Anderson HV, Rogers WJ, et al. Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification. Am J Cardiol 2002; 90:821-826.
7. Morrow DA, Rifai N, Sabatine MS, Ayanian S, Murphy SA, de Lemos JA, et al. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. Clin Chem 2003; 49:1396-1398. (Pubitemid 36900627)
8. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227-239. (Pubitemid 38924592)
9. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007; 61:548-553. (Pubitemid 46605227)
10. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165:1192-1198. (Pubitemid 40720745)
11. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 2006; 7:7-11. (Pubitemid 43305205)
12. Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, et al. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Am J Cardiol 2007; 99:885-889. (Pubitemid 46483273)
13. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005; 293:1759-1765. (Pubitemid 40491302)
14. Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: potential association with C-reactive protein. Circ J 2008; 72:415-419. (Pubitemid 351600635)
15. Boulon C, Lafitte M, Richeboeuf V, Paviot B, Pradeau V, Coste P, et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance. Am J Cardiol 2006; 98:1429-1434. (Pubitemid 44779469)
16. Lopez de Sa E, Lopez-Sendon J, Anguera I, Bethencourt A, Bosch X. Prognostic value of clinical variables at presentation in patients with non-ST-segment elevation acute coronary syndromes: results of the Proyecto de Estudio del Pronostico de la Angina (PEPA). Medicine (Baltimore) 2002; 81:434-442. (Pubitemid 35285963)
17. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333:1091.
18. Weir RA, McMurray JJ, Velazquez EJ. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol 2006; 97:13F-25F.
19. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20:457-464.
20. Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 2003; 290:2174-2181. (Pubitemid 37432978)
21. Parakh K, Thombs BD, Bhat U, Fauerbach JA, Bush DE, Ziegelstein RC. Long-term significance of Killip class and left ventricular systolic dysfunction. Am J Med 2008; 121:1015-1018.
22. DeGeare VS, Boura JA, Grines LL, O'Neill WW, Grines CL. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2001; 87:1035-1038. (Pubitemid 32710315)
23. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984; 1:1264-1267. (Pubitemid 14111082)
24. Lip GY, Lydakis C, Beevers DG. Management of patients with myocardial infarction and hypertension. Eur Heart J 2000; 21:1125-1134. (Pubitemid 30438637)
25. Lundberg V, Stegmayr B, Asplund K, Eliasson M, Huhtasaari F. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med 1997; 241:485-492. (Pubitemid 27315829)
26. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123:504-516. (Pubitemid 16101155)
27. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004; 109:714-721. (Pubitemid 38222889)